Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 卫生和社会工作业
Company Introduction 本公司系由梁耀铭等共12名股东作为发起人，以金域有限整体变更为股份有限公司的方式设立。2015年6月11日，金域有限召开股东会并作出决议，同意将金域有限截至2015年3月31日经立信所审计后的公司净资产32,355.34万元按照1:0.587229的比例折为股份公司的股份19,000万股，净资产超过注册资本的部分13,355.34万元作为股份公司的资本公积，金域有限整体变更为股份有限公司。金域有限本次整体变更为股份公司时12名发起人股东的出资已经立信所于2015年7月15日出具的信会师报字[2015]第114556号《验资报告》审验，并于2015年7月24日获得了广州市工商局核发的注册号为440101000165877的《营业执照》。
Main Business 从事第三方医学检验及病理诊断业务的独立医学实验室，主营业务为向各类医疗机构等（包括医院、妇幼保健院、卫生院等）提供医学检验及病理诊断外包服务，属医疗服务行业，商务服务业
Legal Representative 梁耀铭
Top Executives
董事长：梁耀铭
董事：严婷,曾湛文,汪令来,解强,欧阳小峰
独立董事：樊霞,谢获宝,凌健华
Top 5 Shareholder
Shareholder name Nature Holding Date
梁耀铭限售股+流通A股15.83%30/09/2024
香港中央结算有限公司流通A股10.11%30/09/2024
国创开元股权投资基金（有限合伙）流通A股6.59%30/09/2024
广州市鑫镘域投资咨询合伙企业（有限合伙）流通A股6.10%30/09/2024
广州市圣域钫投资咨询合伙企业（有限合伙）流通A股4.48%30/09/2024
Company Secretary 汪令来
Solicitors 北京市中伦律师事务所
Auditors 立信会计师事务所（特殊普通合伙）
Tel No 020-29196326
Fax No 020-28078333
Website www.kingmed.com.cn
Email sid@kingmed.com.cn
Company Address
Register: 广东省广州市国际生物岛螺旋三路10号
Office: 广东省广州市国际生物岛螺旋三路10号
Listing Date 08/09/2017
Shares Capital
Shares Capital: 463,258,275
Total A Share: 463,258,275
Listed A Share: 460,134,577
Non-tradable A Share: 3,123,698
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 1.380
DPS(RMB)* ¥ 0.880
NBV Per Share(RMB)* ¥ 17.840
Market Capitalization(RMB) 14.471B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.